SYK logo

SYKStryker Corp.

$307.47
$4.73
(1.51%)
Today
Updated: 02:18 PM EDT
EarningsJul 30
Mkt Cap$119.69B
Vol1.1M
News
all
press releases
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Stryker faces cyberattack fallout, but strong procedure demand, record Mako adoption and global expansion continue to support long-term growth.
Zacks
News Placeholder
More News
News Placeholder
Why Is Prestige Consumer Healthcare (PBH) Up 3.6% Since Last Earnings Report?
Prestige Consumer Healthcare (PBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Medtronic Bets on Ablation, Robotics, and Hypertension
MDT is betting on ablation, robotics and hypertension therapies as next growth drivers, but tariffs, FX and pricing pressures cloud near-term upside.
Zacks
News Placeholder
Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story
ABT's Exact Sciences acquisition expands its cancer diagnostics portfolio as new data and screening guidelines strengthen growth prospects.
Zacks
News Placeholder
Is Medtronic Stock a Buy at 14x Forward Earnings?
MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.
Zacks
News Placeholder
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?
ISRG lifts margins despite tariffs, using scale, cost cuts and da Vinci 5 adoption to offset inflation as 2026 cost pressures build.
Zacks
News Placeholder
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom
Globus Medical is riding on musculoskeletal market growth with strong Q1 sales gains, double-digit spine growth, and rising trauma demand across key product lines.
Zacks
News Placeholder
Solventum Trends for 2026: AI Coding, Tariffs, and Margins
SOLV heads into 2026 balancing AI coding growth, cost savings, tariff pressure and a potential 2027 margin risk tied to its 3M supply deal.
Zacks
News Placeholder
Stryker Corporation (SYK) Expands Trauma Portfolio with Pangea Plating System Platform in Europe
Stryker Corporation (SYK) Expands Trauma Portfolio with Pangea Plating System Platform in Europe...
Yahoo! Finance: News
News Placeholder
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?
Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
<
1
2
...
>

Advertisement|Remove ads.